FormDSignal
47

TCGX Asia Life Sciences Fund I closes $600M institutional venture fund

Fund raise update · Venture capital · Closed · PALO ALTO, CA · Form D/A filed 2026-10-07 · sponsor: TCGX · all Tcgx Asia Life vehicles

TCGX Asia Life Sciences Fund I, a Cayman Islands-based venture capital fund, has closed its $600M offering with 70 institutional investors under Regulation D exemption 3(c)(7). The fund is based in Palo Alto and completed its first sale on July 30, 2026.

$100M+ sold3(c)(7) — qualified purchasersVenture capital

How this compares

  • $600M is larger than 99% of the 7,720 venture capital fund launches with a stated size in the last two years; the median is $1.1M.
  • Among 1,632 fund launches filed from CA in the same window it is larger than 99%; the CA median is $19M.
  • Across 443 venture capital sponsors with more than one launch on EDGAR, the median gap between consecutive funds is 3 months.
  • This is the sponsor's 2nd fund launch on EDGAR; the previous one, TCGX Asia Life Sciences Fund I, L.P., was filed 2 months earlier at $400M.

Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.

TCGX on EDGAR

Earlier and related filings by the same issuer and sponsor. All Tcgx Asia Life vehicles →

People on the filing

CHEN YUDirector

Signed by Chen Yu, Director of the Ultimate General Partner.

Why now — by persona

  • Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans.